TRANSGENE (Euronext Paris: TNG), a biotechnology company designing and developing virus-based immunotherapies against cancers and infectious diseases, has signed a collaborative research agreement with Medesis Pharma with exclusive license options to co-develop an...
The use of AONYS®-API microemulsions will allow effective delivery of APIs targeting specific genes or proteins in tumors, resulting in tumor growth inhibition and shrinkage. Once the therapeutic potential of the Aonys®-API combination has been validated in the mouse...
The storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication on an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.Technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance by your ISP, or additional third-party records, information stored or retrieved for this purpose alone generally cannot be used to identify you.
Storage or technical access is required to create user profiles to send advertising, or to track the user across one or multiple websites for similar marketing purposes.